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Purpose/Objective: To evaluate the correlation between the 
reference DWH of bladder wall (DWH) outlined by using MRI images 
and DVH of bladder including filling, dose surface (DSH) and DVH of 
artificial bladder wall in prostate cancer patients planned both with 
3D-conformal and IMRT techniques. 
Materials and Methods: 27 prostate cancer patients were submitted 
to CT and MRI scans that were used to draw bladder walls. External 
bladder surfaces were then used to create artificial bladder walls 
applying automatic contractions of 5 (DVH5), 7 (DVH7) and 10 mm 
(DVH10). For each patient a 3DCRT (box technique) and an IMRT (5 
fields) treatment plan was generated prescribing at ICRU reference 
point 77.4 Gy (1.8 Gy/fr) to PTVprostate and 61.2 Gy (1.8 Gy/fr) to 
PTVprostate+seminal vesicle Gy(1.8Gy/fr). For all the patients the 
mean difference and standard deviation between the DWH and the 
other surrogates, both in percentage (%) and absolute volume(cm3), 
was calculated and considered for the analysis. Correlation was 
quantified for selected dose-volume/surface parameters by R 
Spearman correlation coefficient. 
Results: %DWH was found to be correlated to DVH5, DVH7 and DVH10 
(maximum average deviations below 2%, SD<5%) with DVH5 that 
showed the best agreement. Slightly better correlation was found for 
absolute (R=0.80-0.94) compared to relative (R = 0.66-0.92) 
histograms. DSH was also foundto be highly correlated to DWH 
(maximum difference<2% and 9% for 3DCRT andIMRT, respectively, 
and R>0.64), although slightly higher deviations were generally found. 
DVH was not a good surrogate of DWH (R<0.7 for most ofparameters). 
When comparing the two treatment techniques, Spearman’s 
correlation coefficients were significantly lower for IMRT compared to 
3DCRT both in relative (p=0.002) and absolute (p=0.0007) values. 
Conclusions: DVH of the bladder including filling wasn’t a good 
surrogate of DWH. DSH resulted to be correlated to DWH as well as 
DVH5,7,10 with slightly better results for absolute compared to 
relative histograms. As far as treatment planning techniques, 
Spearman’s correlation coefficients for IMRT planning resulted 
significantly lower compared to 3DCRT.  
These results suggest to use DVH of the bladder wall obtained by 
performing automatic 3D contractions of external surface of the 
bladder inclinical practice.  
The study is supported by a grant from Associazione Italiana Ricerca 
sul Cancro (AIRC-IG13090) 
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Purpose/Objective: The large amount of images taken during image 
guided/adaptive treatments, increases the possibility to assess the 
early response of tissues to the treatment. The possibility of early 
(i.e. during the first weeks of treatment) measuring image-based 
parameters that may potentially predict the outcome of the 
treatment in terms of both tumour response and toxicity is of 
particular interest. 
Regarding head-and-neck cancer (HNC), parotid glands (PGs) are 
known to experience large deformation and this may be related to 
acute toxicity (i.e. xerostomia). The aim of this study is to found 
image based score parameters that could be useful to early predict 
final PG variations. 
Materials and Methods: 92 PGs (46 patients) from two Institutions 
(group A and B) were analyzed based on CT images acquired during 
IMRT treatment. Patients were treated with radiotherapy (+ 
concomitant chemotherapy) to 58.1/70 Gy in 35 fractions (median 
values, dose of tumor and nodes PTVs), 29 with SIB approach. For all 
patients, diagnostic kVCT images were acquired at the begin of the 
treatment and at the end and additional kVCTs were acquired during 
the treatment, weekly in group A, one at mid-treatment in group B. 
Image registration was performed between initial CT and the others, 
using an in home developed non-rigid approach based on free-form 
deformation (FFD) and B-splines. PG contours, drawn by experts on 
the initial CT, were automatically propagated to the other images 
using a previously validated algorithm. 
PG deformations were described by the rates of density variation (rΔρ 
[HU/day]), volume variation (rΔvol [mm3/day]) in different parts of 
treatment. Student t-test, multi-variate logistic (MVA) including ROC 
curve analysis and assessment of predictive value of the models based 
on area under the curve (AUC) evaluations were performed. 
Results: As shown in Figure 1, PG density and volume rates are larger 
during the first weeks of treatment, especially for density rate 
variation r?ρ where it results to be highly significant (group A: -0.495 
vs -0.046, p-value=0.0001). When considering the risk of experiencing 
a large density or volume change at the end of therapy (defined as a 
value larger of the quartile of the population), logistic regression 
indicates that they can be predicted by the changes in the first two 
weeks with a moderately high predictive value (AUC > 80%). Similar 
results with a lower predictive value (AUC around 70%) were found 
when looking to the mid-term changes of A+B groups. 
 
  
Conclusions: The rate of PG volume and density variations is larger at 
the begin of the treatment; this effect is more pronounced for density 
changes. Based on the early variations, it is possible to predict with a 
good approximation the final PG changes. This result may be used to 
early identify patients which may be subject to larger variations and 
then possibly selected for adaptive re-planning. 
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Purpose/Objective: The development of the Utrecht design, hybrid 
1.5T MRI linear accelerator offers the ability to perform online MRI-
guided adaptive radiotherapy (ART). This MRI guided ART allows for 
the creation of an optimal treatment plan on the actual anatomy for 
every single treatment fraction. Hereby margins can be reduced due 
to the absence of inter fraction motion and set-up errors. 
Additionally, MRI's superior soft-tissue contrast allows direct tumor 
visualization instead of indirect features used on a CT. These features 
open the possibility for dose escalation. Yet this daily optimization 
requires a fast automated contour propagation and treatment 
planning to be feasible in clinical practice. We propose and evaluate 
an automated workflow for online MRI guided ART for rectal cancer 
boost therapy. 
Materials and Methods: Until now, 10 rectal cancer patients (T2-3 N0-
1 M0-1) underwent pre-treatment and 3-4 consecutive daily fraction 
T2 MR scans. Pre-treatment target volumes and OAR were delineated 
by an experienced radiation oncologist. These contours were then 
propagated to the 3 or 4 consecutive daily fraction MRI's by 
deformable image registration (DIR) of the pre-treatment MRI to the 
fraction MRI. This automated propagation was performed via a multi 
step approach (consecutive Euler, affine and B-spline transforms) 
using the Elastix toolkit (Klein 2010). PTV margins between 1 - 8 mm 
in plane and 4 - 8 mm out of imaging plane, were then applied to the 
transformed CTV and GTV. For each margin, a 7 beam IMRT boost 
treatment plans was made. A dose of 50 Gy was prescribed to the 
PTVCTV and a total dose of 60 Gy was prescribed to the PTVGTV. For 
planning, a fast Monte Carlo based IMRT planning system was used 
(Bol 2012). The dosimetric evaluation of the treatment plans was done 
on golden standard contours. These are obtained by manual correction 
and approval by radiation oncologist of the propagated contours. D99% 
of the gold standard CTV and GTV were evaluated. When a D99% 
